Essential Oil-Herbal Sachet Trial Data for Hemodialysis Patients, 2022-2023

Ye Lin published a dataset from a single-center randomized trial investigating a combined olfactory intervention for sleep quality and anxiety in maintenance hemodialysis patients. The trial recruited 88 eligible patients from Yongkang Hospital of Traditional Chinese Medicine between January 2022 and December 2023. Outcomes were assessed using the Pittsburgh Sleep Quality Index and Hospital Anxiety and Depression Scale-Anxiety subscale at five time points up to month 3.

Use Cases

• Analyzing the effect of olfactory interventions on sleep quality based on PSQI scores over time.
• Evaluating anxiety reduction in hemodialysis patients based on HADS-A subscale scores.
• Studying adherence to non-pharmacological interventions based on reported application and inhalation rates.
• Comparing adverse event rates between intervention and control groups in a clinical trial context.

Strengths

• Dataset includes longitudinal data with assessments at baseline, day 7, day 15, month 1, and month 3.
• Primary endpoint results are specific: PSQI global score difference at month 3 was -5.37 (95% CI, -6.29 to -4.45; P < 0.001).
• Adherence metrics are quantified: mean adherence was 86.7% for bedtime application and 83.4% for dialysis-session inhalation.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• The trial was conducted at a single center with 88 patients, which may limit generalizability.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

figshare

Collection Method

Data collected from a single-center, open-label, parallel-group randomized trial.

Time Range

January 2022 to December 2023

Freshness

Last updated 2026-06-04 11:15:43; freshness should be verified.

Geography

Yongkang Hospital of Traditional Chinese Medicine